Medtronic plc
MDT
Ранг среди акций
#183
Medtronic plc is a leading global medical technology enterprise that invents,... Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Цена акции
$94.59
Последняя синхронизация: 2026-10-20
Рыночная капитализация
$120.99B
Изменение (1 день)
1.76%
Изменение (1 год)
-1.30%
Страна
IE
Торговля Medtronic plc (MDT)
Категория
Healthcare
Коэффициент P/E для Medtronic plc (MDT)
Коэффициент P/E на May 2026 TTM: 21.39
Согласно последним финансовым отчетам и цене акций Medtronic plc, текущий P/E (TTM) составляет 21.39. В конце 2024 у компании был P/E на уровне 28.98.
История P/E компании Medtronic plc с 2000 по 2026
P/E на конец каждого года
| Год | P/E коэффициент | Изменить |
|---|---|---|
| 2026 (TTM) | 21.39 | -8.48% |
| 2025 | 23.37 | -19.35% |
| 2024 | 28.98 | -9.95% |
| 2023 | 32.18 | 15.76% |
| 2022 | 27.80 | -43.06% |
| 2021 | 48.83 | 75.64% |
| 2020 | 27.80 | 9.46% |
| 2019 | 25.40 | -28.52% |
| 2018 | 35.53 | 24.91% |
| 2017 | 28.44 | -9.80% |
| 2016 | 31.53 | -0.78% |
| 2015 | 31.78 | 65.27% |
| 2014 | 19.23 | 40.13% |
| 2013 | 13.72 | 23.30% |
| 2012 | 11.13 | -23.39% |
| 2011 | 14.53 | -6.85% |
| 2010 | 15.60 | -5.77% |
| 2009 | 16.55 | -32.91% |
| 2008 | 24.67 | 13.60% |
| 2007 | 21.72 | -8.07% |
| 2006 | 23.62 | -33.21% |
| 2005 | 35.37 | 13.16% |
| 2004 | 31.26 | -13.97% |
| 2003 | 36.33 | -33.97% |
| 2002 | 55.03 | 7.28% |
| 2001 | 51.29 | -9.73% |
| 2000 | 56.83 | 0.00% |
P/E для схожих компаний или конкурентов
| Компания | P/E Ratio | Разница P/E | Страна |
|---|---|---|---|
| 33.11 | 54.80% |
US
|
|
| 28.94 | 35.33% |
US
|
|
| 17.34 | -18.93% |
US
|
|
| - | - |
DE
|
|
| 49.68 | 132.30% |
US
|
Как читать P/E Ratio?
Коэффициент цена/прибыль (P/E Ratio) отражает соотношение между ценой акции компании и её прибылью на акцию.
Низкий, но положительный P/E говорит о том, что компания приносит высокую прибыль при низкой оценке и может быть недооценена. Высокий отрицательный (близкий к 0) P/E указывает на значительные убытки.
Компании с P/E выше 30 или отрицательным считаются "акциями роста" — инвесторы ожидают роста или будущей прибыли.
Компании с положительным P/E ниже 10 считаются "ценностными акциями", т.е. уже прибыльны, но с низким потенциалом роста.